Insider Trading & Executive Data
Start Free Trial
53 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Innovative Eyewear (Lucyd) designs, manufactures and sells Bluetooth-enabled smart eyeglasses and sunglasses that combine prescription/sun lenses with open-ear audio and voice‑assistant integration. Products include direct-to-consumer Lucyd Lyte models and cobranded Nautica, Eddie Bauer and Reebok lines, an ANSI‑certified safety offering (Lucyd Armor), and a newly introduced Lucyd Pro subscription for software/chat access. The business is capital‑light with U.S. design/software and China-based manufacturing, sells through e‑commerce (majority of revenue), Amazon and 300+ wholesale accounts (over 540 retail locations), and emphasizes rapid SKU expansion, influencer marketing and a growing patent portfolio (~115 patents/applications).
Given the company’s stage and MDA disclosures, a meaningful portion of executive pay is likely equity‑linked: management already cites material stock‑based compensation expense and the company has relied on equity financings and warrant exercises to fund operations. Compensation targets and payout triggers in this environment will likely emphasize revenue/unit growth (e‑commerce velocity, retail rollouts, SKU momentum), margin recovery (mitigating tariffs, lower‑cost SKUs like Armor/Reebok), subscription/recurring software uptake, and R&D/IP milestones; these are the metrics management highlights in filings. The small headcount and founder/licensor relationship (exclusive perpetual license from Lucyd Ltd.) increase the likelihood of negotiated, performance‑contingent packages and related‑party considerations in pay disclosures, while full valuation allowance on tax assets and ongoing cash burn mean dilution‑sensitive equity awards and retention grants are probable.
Insider activity at Lucyd will likely correlate with product launches, retail account rollouts, tariff or supply‑chain developments, and financing events—each materially affects near‑term liquidity and margins (e.g., April 2025 tariffs materially impacted Q2 margins). Because stock‑based compensation is a material expense and the company has used equity/warrant financings, expect insider exercises and subsequent sales to cover tax or liquidity needs; monitor Form 4s around earnings, ATM offerings and related‑party disclosures. Regulatory and operational factors—ANSI safety certification, prescription fulfillment partner arrangements, connected‑device privacy/firmware updates, and concentrated manufacturing in China—create event risks that could prompt opportunistic insider trades; small float and thin trading can amplify the market impact of any insider sales or buys.